{"id":9401,"date":"2025-12-29T23:02:21","date_gmt":"2025-12-29T23:02:21","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/12\/29\/wegovy-pill-price-novo-nordisk-strategy-weight-loss-drugs\/"},"modified":"2025-12-29T23:02:21","modified_gmt":"2025-12-29T23:02:21","slug":"wegovy-pill-price-novo-nordisk-strategy-weight-loss-drugs","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/12\/29\/wegovy-pill-price-novo-nordisk-strategy-weight-loss-drugs\/","title":{"rendered":"STAT+: With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market"},"content":{"rendered":"

STAT+: With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine from Eli Lilly, as the Danish drugmaker tries to seize market share among consumers paying cash for blockbuster GLP-1 therapies.<\/p>\n

Novo will sell the highest doses of its Wegovy pill, cleared<\/a> last week, at $299 a month for patients paying the company directly, according to the drug\u2019s website<\/a>. Meanwhile, Lilly has said<\/a> it plans to sell its weight loss pill orforglipron at up to $399 a month following approval, which is expected in the next few months.<\/p>\n

The Wegovy pill\u2019s price is also lower than the prices of injectable drugs when sold directly to patients \u2014 $349 for injectable Wegovy and $449 for Lilly\u2019s Zepbound.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Elaine Chen
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine from Eli Lilly, as the Danish drugmaker tries to seize market share among consumers paying cash for blockbuster GLP-1 therapies. Novo […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,2594,2595,2282,2176,2155,2152,2648],"tags":[2150],"class_list":["post-9401","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-eli-lilly","category-novo-nordisk","category-obesity","category-pharma","category-pharmaceuticals","category-stat","category-weight-loss","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/9401"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=9401"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/9401\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=9401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=9401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=9401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}